Case of the Month

Topics
What's Worse Than a Migraine?
Uveitic Glaucoma
Episodic Damage to the RNFL
The Importance of Risk Factors for Younger Patients
Glaucoma and Retinal Pathologies
Bilateral NAION
Neuroretinal Rim Defects
Optic Neuritis
Iridotomy
Angle Closure Due to Topamax
Iridotomy Part II: Was It Successful?
Uveitis and Elevated IOP
Is This Glaucoma?
Anomalous Optic Nerve
Asymmetry
Detecting Visual Field Progression in Glaucoma
Unusual Side Effect of Topical Glaucoma Medication
Angle Recession
IOL Iris Defect
Glaucoma Damage in a Younger Patient
OCT and Ocular Lesions
Monitoring Conjuctival Lesions
Visual Fields vs. Optic Nerve Imaging
Sjogren's Syndrome
Duane's Retraction Syndrome
 

Webinars

Topics
Cirrus HD-OCT Technology
Why Measure the Macula in Glaucoma
NGS to Offer Webinars
SAMPLE NGS WEBINAR
Clinical Pearls from The OHTS Study
Fluctuations in IOP
Using a Smart Phone or Tablet for Webinars
Optic Nerve Evaluation
Insights into the Use of Technology: Glaucoma Change Over Time
The Use of OCTs in Glaucoma
Will the Real IOP Please Stand Up
Using Chat During a Webinar
Instructions for Joining an NGS Webinar
Ganglion Cell Analysis
Disc Hemorrhage
Peripapillary Atrophy
CE Approval for Webinars will be Obtained from Individual States
Patient Compliance
Setting up Webinar Audio on Smart Phones
Discussions
Re: Using a Smart Phone or Tablet for Webinars
sign up for Nov 18 webinar
Re: Using a Smart Phone or Tablet for Webinars
No, the chat window is part of the WebEx video conferencing. You need to enable it once you are on the webinar by clicking on the grey speech bubble in
read more
Re: Using a Smart Phone or Tablet for Webinars
I cant seem to get the chat window open? Is this the same?
 

Industry News

Topics
New FDA Approval for Lumigan
Alcon's Travatan Z Solution Receives FDA Approval
Alcon's Travatan Z and Systane Use Different Preservatives
Pfizer Sponsors New "All Eyes on Glaucoma" Website
CLIA Waivers
Bausch + Lomb New Glaucoma Drug
Discussions
Re: Alcon's Travatan Z Solution Receives FDA Approval
Dr. Ghosh, If you click on the Alcon logo on the lower right side of this website, it will bring you to Alcon's Travatan website where there is complete product information
read more
Re: Alcon's Travatan Z Solution Receives FDA Approval
I would like to receive some full text about the new approved drug Travatan Z
 

Clinical Guidelines

Topics
CCT: Is is time to say YES?
The Role of CCT in Glaucoma Patients
More CCT
The Paradox of IOP
Should We Treat All Ocular Hypertensives?
Beta Blockers in Glaucoma Management
Re-Defining Ocular Hypertension
Implications of Macro-Disc Asymmetry in Glaucoma Suspects
Nine-Year Changes in Intraocular Pressure: The Barbadoes Eye Studies
Discussions
Re: The Paradox of IOP
At a recent education event one of our attendees asked me to find out the incidence of ocular hypertension in the general population. I could not identify a study noting
read more
 

Pharmacology Update

Topics
Extravan: Alcon Pharmaceuticals
Mechanism of IOP Reduction with Travoprost
Discussions
Re: Extravan: Alcon Pharmaceuticals
Extravan has not yet received FDA approval in the U.S. However, Alcon's Travatan/Timolol fixed combination is approved as DuoTrav in Europe, Australia and Canada. It is approved for dosing in
read more
Re: Extravan: Alcon Pharmaceuticals
Dr. Fisher - I have not used any combo drugs at this time. I have asked Paul Smith from Alcon to post an answer. Let's see what Alcon reports. Thanks
Re: Extravan: Alcon Pharmaceuticals
Extravan is QD dosing. Timolol is QAM and Travatan is QHS. When is Extravan used?
 

In Your Office

Topics
Glaucoma Flowsheet
Tonometer Calibration
Pachymetry Coding
BCBS Coverage of SCODI Services
Expanded Coverage of Glaucoma Screening Services
Coding Update: 92135 Deleted and Replaced
ABO Certification Review Materials
Small Fee Reduction in CMS Payments in 2015
Moist Heat Compresses
Information about Omega-3s
Discussions
Re: Moist Heat Compresses
You also discussed information and possible group pricing about a gland expresser and said you would provide information regarding that instrument. Please post that information. Thank you.
Re: ABO Certification Review Materials
Could you please send the glaucoma review information and uveitis labs worksheets to lmillod@ptd.net.
Re: ABO Certification Review Materials
I also attended the SECO course, could you please email the ABO certification review material to davidfierceod@yahoo.com. Thanks!
 

Glaucoma Watch

Topics
Interesting Glaucoma Cases
From Ocular Hypertension to Glaucoma: How to Predict Conversion
Neckties and IOP: The Controversy Continues
Introduction to the National Glaucoma Society
Case Presentation: Optic Nerve Imaging
NGS Residency Award and Lecture
Optic Nerve Head Measurements with the HRT III
Case Presentation: Laser Imaging Detects Early ON Damage
Is the Optic Disc "Sinking" or "Cupping" in Glaucoma?
Interview with Dr. Barry Barresi
Glaucoma Continuum
Undiagnosed Open Angle Glaucoma: The Thessaloniki Eye Study
The Prevalence of Open-angle Glaucoma Among Blacks and Whites 73 Years and Older
Altered Nitric Oxide System in Patients with Open-Angle Glaucoma
Oxidative Stress in Glaucoma: A Burden of Evidence
Gonioscopy Videos
Glaucoma Risk and the Consumption of Fruits and Vegetables in Older Women
Programs to Optimize Adherence in Glaucoma
Corneal Hysteresis
Visual Field Interpretation
Study Questions link between Glaucoma and Alzheimer's Disease
Checking Color Vision
IOP Asymmetry as Glaucoma Risk Factor
Glaucoma Risk Calculators
Dr. David Calkins Discusses Catalyst for A Cure
Smart Phone Biosensor
Handheld OCT
Sustained Release IOP Therapies
Introduction to Corneal Hysteresis
FDT Perimetry
Visual Fields Overview
National Glaucoma Symposium 2017
Gonioscopy Slides from 2017 National Glaucoma Symposium
Discussions
Re: National Glaucoma Symposium 2011
Another successful conference! See you next year July 28-30, 2012.
Re: Undiagnosed Open Angle Glaucoma: The Thessaloniki Eye Study
In reading the details found within the journal article highlighted above, it is evident that significant efforts must be made to educate the population better as to the risks of
read more
Re: Oxidative Stress in Glaucoma: A Burden of Evidence
This article manifests some interesting insight. So far, we have failed to address the fundamental question: Why (among the one million densely packed nerve fibers in a 1.5 mm sized
read more